In-patient Treatment of 165 Adolescents with Emotional and Conduct Disorders a Study of Outcome

1993 ◽  
Vol 162 (3) ◽  
pp. 345-352 ◽  
Author(s):  
Peter Wells ◽  
Brian Faragher

A two-year follow-up study of 165 teenagers with conduct and emotional disorders treated as in-patients on a regional adolescent unit (YPU) is described. The target types of behaviour for each subject were scored independently by the teenager, the parent or guardian, and the professional referrer before admission and at one month, one year and two years after discharge. The significant overall improvement in behaviour observed at one month after discharge was sustained at one and two years. Thirty-three subjects who abandoned treatment within six weeks of admission had made significantly less progress than the fully treated group at one month after discharge, but there were no significant differences at the one- and two-year evaluations. Two years after treatment, between 69% and 79% of the 132 subjects who completed treatment were regarded as improved, depending on which respondent made the assessment. Adolescents who completed treatment had different characteristics from those who terminated treatment prematurely and were more likely to be girls in care referred by social services.

2021 ◽  
Vol 11 (11) ◽  
pp. 1234
Author(s):  
Gabriele Melegari ◽  
Enrico Giuliani ◽  
Chiara Dallai ◽  
Lucia Veronesi ◽  
Elisabetta Bertellini ◽  
...  

Introduction: An infection by COVID-19 triggers a dangerous cytokine storm, so tocilizumab has been introduced in Italy as an agent blocking the cytokine storm. This paper aims to describe the one-year survival of ICU patients treated with tocilizumab. Methods: This observational study enrolled all patients confirmed to be infected by COVID-19 who were admitted to the ICU in our center. We offered tocilizumab to all non-septic patients if they did not present any contraindications. Results: We enrolled 68 ICU patients in our center on 72 occasions during the enrollment period; we excluded four patients due to study criteria. The one-year mortality hazard ratio of treated patients was 0.64, with a confidence interval of 0.31 to 1.19, with p = 0.169. Among the survivors, 32 of 35 patients answered the phone interview (14 patients in the treated group and 18 in the untreated group); overall, the effect of COVID-19 on quality of life was 58.14%. These effects were lower in the tocilizumab group, with p = 0.016 *. Conclusions: Our observational data follow the most relevant largest trial. Patients treated with tocilizumab had lower rates of new-onset symptoms later COVID-19 ICU hospitalizations. As reported by recent medical literature, the presence of these symptoms suggests that a follow-up program for these types of patients could be useful.


1984 ◽  
Vol 14 (3) ◽  
pp. 597-604 ◽  
Author(s):  
M. E. Garralda

SynopsisIn a controlled study, 20 children with hallucinations and emotional or conduct disorders were followed up into adulthood. The mean follow-up time was 17 years and the mean age at follow-up was 30 years. Hallucinations in childhood did not carry an increased risk for psychoses, depressive illness, organic brain damage or other psychiatric disorders. The continuation of hallucinations and episodes of altered awareness in some of the subjects may indicate a special predisposition to hallucinate.


1978 ◽  
Vol 132 (5) ◽  
pp. 500-505 ◽  
Author(s):  
Ian Berg ◽  
Dorothy Fielding

SummaryThirty-two school-phobic youngsters of mean age 13 years were randomly allocated to two treatment groups after stratifying for sex. Length of in-patient management in a psychiatric hospital unit for young adolescents was evaluated. One group was admitted for three months and the other for six. Care was taken to ensure that cases had been fairly distributed between the groups by comparing them on a variety of clinical features. Follow-up assessments were carried out in a reliable fashion at six months, one year and two years after discharge. Outcome, overall, was similar to that found in a previous follow-up study for the same unit, in that symptoms of emotional disturbance and social impairment tended to persist in a considerable proportion of cases over the period of review. Length of stay in hospital did not affect outcome as far as the boys were concerned; the findings in relation to the girls was less certain and it seems likely that longer in-patient treatment improves outcome in school-phobic girls.


2007 ◽  
Vol 32 (4) ◽  
pp. 427-433 ◽  
Author(s):  
M. IKÄVALKO ◽  
E. T. SKYTTÄ ◽  
E. A. BELT

Revision metacarpophalangeal arthroplasty after silicone implant arthroplasty is frequently complicated by severe bone loss, osteolysis and diaphyseal perforations. Impacted, morselised allografts are frequently used to treat bone loss in revision surgery. A new method of treatment using bioreconstructive poly-L/D-lactic acid (PLDLA) joint scaffold and allograft bone packing, after complete removal of the original silicone implants, allows recovery of bony deficiencies, correction of malalignment and improves function of the hand. This article presents the one-year results of a prospective, non-randomised clinical and radiographic follow-up study of 21 patients with 52 revision metacarpophalangeal arthroplasties using the PLDLA implants and allograft bone packing.


VASA ◽  
2012 ◽  
Vol 41 (2) ◽  
pp. 120-124 ◽  
Author(s):  
Asciutto ◽  
Lindblad

Background: The aim of this study is to report the short-term results of catheter-directed foam sclerotherapy (CDFS) in the treatment of axial saphenous vein incompetence. Patients and methods: Data of all patients undergoing CDFS for symptomatic primary incompetence of the great or small saphenous vein were prospectively collected. Treatment results in terms of occlusion rate and patients’ grade of satisfaction were analysed. All successfully treated patients underwent clinical and duplex follow-up examinations one year postoperatively. Results: Between September 2006 and September 2010, 357 limbs (337 patients) were treated with CDFS at our institution. Based on the CEAP classification, 64 were allocated to clinical class C3 , 128 to class C4, 102 to class C5 and 63 to class C6. Of the 188 patients who completed the one year follow up examination, 67 % had a complete and 14 % a near complete obliteration of the treated vessel. An ulcer-healing rate of 54 % was detected. 92 % of the patients were satisfied with the results of treatment. We registered six cases of thrombophlebitis and two cases of venous thromboembolism, all requiring treatment. Conclusions: The short-term results of CDFS in patients with axial vein incompetence are acceptable in terms of occlusion and complications rates.


2008 ◽  
Vol 149 (43) ◽  
pp. 2053-2059
Author(s):  
Mária Bényi ◽  
Zsuzsanna Kéki ◽  
Péter Rákos-Zichy ◽  
Vilmosné Panics ◽  
Ivett Honvéd

Az időskori esések egészségügyi, szociális, gazdasági terhe igen jelentős napjainkban is. A demográfiai változások következtében a problémával továbbra is számolni kell. Európa-szerte nagy figyelem hárul az időskori balesetek megelőzésére. A szerzők egy európai uniós program keretében kutatást végeztek a szociális otthoni körülmények között élők esési gyakoriságáról, illetve annak okairól. Cél: A kutatás célja az volt, hogy az esések gyakoriságán kívül azok háttere is feltárásra kerüljön, különös tekintettel a gyógyszerfogyasztásra. Adatok, módszer: Egységes kérdőív alapján két szociális otthonban, amelyeknek együtt 1016 lakója van, egyéves vizsgálat történt. A munka során az ápolószemélyzet rögzített minden esést és azok körülményeit, következményeit. Az okok között kiemelt helyen szerepeltek a környezeti tényezők mellett a fogyasztott gyógyszerek. Ez utóbbiakat az elnevezésük alapján tovább vizsgáltuk, a hatásukat és az elesést okozó mellékhatásukat illetően. Az adatfeldolgozás SPSS 14.0 programmal történt. Eredmények: A szociális otthonok lakói között 1013 esés történt a 12 hónap során. Az esetek kétharmadában valamilyen egészségügyi ellátást igényelt az elesett személy. A leggyakrabban horzsolás, zúzódás, illetve bőrsérülés jött létre (20–24%). Combnyaktörés 3%-ban, egyéb törés 1,8%-ban következett be. Szinte minden lakó fogyaszt gyógyszert: 19% háromfélét vagy annál kevesebbet, a többség ennek a többszörösét. Az egy főre jutó maximális gyógyszerfogyasztás 19 volt, az átlag 6. Az esést okozó mellékhatások tekintetében a maximum 43 volt, az átlag 14. Az egyes mellékhatások gyakoriságát, halmozódását külön is bemutatjuk. Következtetések: Az időskori esések száma, aránya jelentős a szociális otthonban élők körében. Ennek egyik oka lehet az igen nagy mennyiségű gyógyszerfogyasztás, amelynek mellékhatása következtében nő az elesés rizikója.


Sign in / Sign up

Export Citation Format

Share Document